Efficacy of TAP Block in Cesarean Section Patients
Phase 3
Completed
- Conditions
- Pain Control
- Registration Number
- NCT03493828
- Lead Sponsor
- New York Presbyterian Brooklyn Methodist Hospital
- Brief Summary
TAP Block done with 2 different concentrations of bupivacaine and placebo
- Detailed Description
TAP Block was done using 2 different concentrations of bupivacaine (0.5% and 0.25%) and placebo and the post operative sedation was measured in each arm and compared together.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
- Healthy pregnant women
Exclusion Criteria
- Allergy to local anesthetics
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Effect of Transversus Abdominis Plane (TAP) Block Using Either 0.5% or 0.25% Bupivacaine on Analgesia for Cesarean Section Patients When Compared to Placebo. 0-24 hours The total the number of Patient Controlled Analgesia (PCA) boluses used by the patients postoperatively within 24 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New York Methodist Hospital
🇺🇸Brooklyn, New York, United States
New York Methodist Hospital🇺🇸Brooklyn, New York, United States